Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight ...

A month has gone by since the last earnings report for Techne (TECH). Shares have lost about 15.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up ...

Bio-Techne Corp. closed 27.36% short of its 52-week high of $85.57, which the company reached on May 15th.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Zurcher Kantonalbank Zurich Cantonalbank decreased its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 2.8% in the 4th quarter, according to the company in its most recent Form 13F ...

Buy” on shares of Bio-Techne as a short-term investment idea. The firm expects Bio-Techne to report fiscal Q3 results in line or above ...

Argus analyst David Toung lowered the firm’s price target on Bio-Techne (TECH) to $90 from $95 and keeps a Buy rating on the shares after its ...

Bio-Techne was ordered on Feb. 26 by an arbitrator to pay its former CEO Charles Kummeth about $36 million after providing the wrong expiration date on granted options to buy about 779k shares of ...

The latest Techne UK weekly tracker poll suggests that Reform UK has hit a ceiling in support as Nigel Farage’s leadership is ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon existing Simple Western platforms that offer ...

A month has gone by since the last earnings report for Techne (TECH). Shares have lost about 15.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...